AstraZeneca PLC (LON:0A4J)
London · Delayed Price · Currency is GBP · Price in USD 93.00
-2.35 (-2.46%)
At close: Jan 28, 2026
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 210.92 billion as of January 30, 2026. Its market cap has increased by 23.08% in one year.
Market Cap
210.92B
Enterprise Value
229.20B
Revenue
43.24B
Ranking
n/a
PE Ratio
30.17
Stock Price
93.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 210.92B, an increase of 4,535.27%. That is a compound annual growth rate of 12.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 210.92B | -1.37% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HSBC Holdings | 220.40B |
| AstraZeneca | 210.92B |
| Shell | 158.99B |
| Rio Tinto Group | 113.15B |
| Unilever | 109.39B |
| Rolls-Royce Holdings | 101.23B |
| British American Tobacco p.l.c. | 94.98B |
| GSK plc | 75.29B |